Evidence map›Paper›PMID 27918880›Full record

ArticleJournal of psychoactive drugs

Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder.

Verena E Metz, Maria A Sullivan, Jermaine D Jones, Elizabeth Evans, Rachel Luba, Jonathan Vogelman, Sandra D Comer

Open access · greenAbstract read
In one paragraph

Article in Journal of psychoactive drugs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Verena E Metza Postdoctoral Research Scientist, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Maria A Sullivanb Study Physician, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Jermaine D Jonesc Assistant Professor of Clinical Neurobiology, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Elizabeth Evansd Postdoctoral Fellow, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Rachel Lubae Research Assistant, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Jonathan Vogelmane Research Assistant, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Sandra D Comere Research Assistant, Department of Psychiatry, Division on Substance Abuse , New York State Psychiatric Institute & Columbia University Medical Center , New York , NY , USA.
Columbia University Irving Medical Center · US

Funding

PHARMACOLOGICAL TREATMENT OF MARIJUANA DEPENDENCEP50DA009236 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KLEBER, HERBERT DAVID · 1994 to 2013
$39.4M
Training and Education CoreU54DA037842 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI LEVIN, FRANCES RUDNICK · 2014 to 2018
$14.3M
Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
NIDA NIH HHS P50 DA009236NIDA NIH HHS T32 DA007294NIDA NIH HHS U54 DA037842
6 · The paper itself

Abstract

In light of New York's recently reinforced strategy to end the AIDS epidemic by expanding testing, treatment, and access to pre-exposure prophylaxis (PrEP), we assessed drug use and sexual risk behaviors, along with HIV/Hepatitis C virus (HCV) transmission and prevention knowledge among non-treatment-seeking adults with opioid use disorder (OUD) in New York City. Over the course of 18 months, volunteers screening for research studies in the Opioid Laboratory at the New York State Psychiatric Institute completed a locally developed self-assessment questionnaire. A total of 138 adults with OUD (24 female, 114 male) with a mean age of 46.5 years (SD = 9.5 yrs) were assessed. Significant differences among the four racial/ethnic subgroups (n = 65 African-Americans, n = 34 Hispanics, n = 31 Caucasians or Whites, n = 8 Multiracial) were found. Whites were the youngest (p = 0.001), most frequently injecting drugs (p < 0.001), and engaged more often in risky drug use and sexual behaviors, although their virus transmission knowledge was comparable to that of the other subgroups. Few participants had heard about PrEP. White opioid users showed the most risk behaviors among races/ethnicities, despite comparable prevention knowledge. Better HIV/HCV prevention interventions targeting individuals with opioid use disorders who are not currently in treatment would be desirable, given their large health burden.

Indexed as

AdultEthnicityFemaleHealth Knowledge, Attitudes, PracticeHepatitis CHIV InfectionsHumansMaleMiddle AgedNew York CityOpioid-Related DisordersRacial GroupsRisk-TakingSelf-AssessmentSexual BehaviorSubstance Abuse, IntravenousEthnicitiesHepatitis CHIVopioid userspreventionrisk behaviors

Identifiers

PMID27918880
PMCPMC5950713
OpenAlexW2559926382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.